<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Suggested doses of parenteral antibiotics commonly used in the treatment of osteoarticular infections in infants and children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Suggested doses of parenteral antibiotics commonly used in the treatment of osteoarticular infections in infants and children</h1>
<div class="graphic"><div class="figure"><div class="ttl">Suggested doses of parenteral antibiotics commonly used in the treatment of osteoarticular infections in infants and children</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup span="2" width="40%"></colgroup> <tbody> <tr> <td class="subtitle1">Intravenous agent</td> <td class="subtitle1">Dose for infants 8 to 28 days of age</td> <td class="subtitle1">Dose for children &gt;28 days of age</td> </tr> <tr> <td>Ampicillin</td> <td>150 mg/kg per day IV divided in 2 doses</td> <td>200 to 400 mg/kg per day IV divided in 4 doses; maximum dose 12 g/day</td> </tr> <tr> <td>Cefazolin</td> <td>100 to 150 mg/kg per day IV divided in 3 doses</td> <td>100 to 150 mg/kg per day IV divided in 3 doses; maximum dose 6 g/day</td> </tr> <tr> <td>Cefepime</td> <td>60 to 100 mg/kg per day IV divided in 2 doses</td> <td>100 to 150 mg/kg per day IV divided in 3 doses; maximum dose 6 g/day</td> </tr> <tr> <td>Cefotaxime</td> <td>150 to 200 mg/kg per day IV divided in 3 doses</td> <td>150 to 200 mg/kg per day IV divided in 3 or 4 doses; maximum dose 8 g/day</td> </tr> <tr> <td>Ceftazidime</td> <td>150 mg/kg per day IV divided in 3 doses</td> <td>125 to 150 mg/kg per day IV divided in 3 doses; maximum daily dose 6 g</td> </tr> <tr> <td>Ceftriaxone</td> <td>50 to 75 mg/kg per day IV in 1 dose</td> <td>75 to 100 mg/kg per day IV divided in 1 or 2 doses; maximum dose 4 g/day</td> </tr> <tr> <td>Clindamycin</td> <td>20 to 30 mg/kg per day IV divided in 3 doses</td> <td>25 to 40* mg/kg per day IV divided in 3 or 4 doses; maximum dose 2.7 g/day</td> </tr> <tr> <td>Daptomycin<sup>¶</sup></td> <td>NA</td> <td> <p>1 through 6 years: 12 mg/kg per day IV in 1 dose</p> <p>7 through 11 years: 9 mg/kg per day IV in 1 dose</p> 12 through 17 years: 7 mg/kg per day IV in 1 dose </td> </tr> <tr> <td>Gentamicin</td> <td>7.5 mg/kg per day IV divided in 3 doses</td> <td>7.5 mg/kg per day IV divided in 3 doses</td> </tr> <tr> <td>Linezolid</td> <td>30 mg/kg per day IV divided in 3 doses</td> <td> <p>&lt;12 years: 30 mg/kg per day IV in 3 doses</p> ≥12 years: 600 mg twice per day IV</td> </tr> <tr> <td>Nafcillin</td> <td>100 mg/kg per day divided in 4 doses</td> <td>150 to 200 mg/kg per day IV divided in 4 doses; maximum dose 12 g/day</td> </tr> <tr> <td>Oxacillin</td> <td>100 mg/kg per day IV divided in 4 doses</td> <td>150 to 200 mg/kg per day IV divided in 4 to 6 doses; maximum dose 12 g/day</td> </tr> <tr> <td>Penicillin</td> <td>150,000 units/kg per day IV divided in 3 doses</td> <td>250,000 to 400,000 units/kg per day IV divided in 4 to 6 doses; maximum dose 24 million units per day</td> </tr> <tr> <td>Vancomycin<sup>Δ</sup></td> <td>Loading dose of 20 mg/kg IV followed by maintenance dose according to serum creatinine as indicated below. The interval between the loading dose and the first maintenance dose should be the same as the dosing interval for the maintenance regimen. This dosing regimen was designed with a target trough concentration of 5 to 10 mg/L.<sup>[1]</sup> <ul class="decimal_heading"> <li>&lt;0.7 mg/dL: 15 mg/kg IV every 12 hours</li> <li>0.7 to 0.9 mg/dL: 20 mg/kg IV every 24 hours</li> <li>1.0 to 1.2 mg/dL: 15 mg/kg IV every 24 hours</li> <li>1.3 to 1.6 mg/dL: 10 mg/kg IV every 24 hours</li> <li>&gt;1.6 mg/dL: 15 mg/kg IV every 48 hours</li> </ul> </td> <td>Refer to UpToDate content related to alternative methods of dosing vancomycin for children older than 28 days<sup>◊</sup></td> </tr> </tbody></table></div><div class="graphic_lgnd">Refer to UpToDate topics on management of osteomyelitis and septic arthritis in children for details regarding indications for particular drugs; recommended doses are for patients with normal renal function and infants born at &gt;34 weeks' gestation. Consultation with an expert in pediatric infectious diseases is suggested for infants born at ≤34 weeks gestation.</div><div class="graphic_footnotes"><p>IV: intravenous; NA: not available; PMA: postmenstrual age; PNA: postnatal age; AUC: area under the curve.</p>
<p>* 40 mg/kg per day is preferred for children ≥3 months of age.</p>
<p>¶ Daptomycin should not be used in children with concomitant pulmonary involvement and is not recommended in children &lt;1 year of age because of the risk of potential effects on muscular, neuromuscular, and/or nervous systems (peripheral and/or central) observed in dogs. It is not approved for the treatment of osteoarticular infections in children; the appropriate dose for osteoarticular infections has not yet been established but is the subject of clinical trials. The doses provided above are those that are recommended for <em>Staphylococcus aureus</em> bacteremia in children.</p>
<p class="extra_spacing_top">Δ Dosing algorithm for vancomycin based upon serum creatinine concentration in neonates born at gestational age &gt;28 weeks. A vancomycin dosing method based upon PMA and PNA is provided as an alternative to the serum creatinine-based method listed above and may be useful in some clinical situations.<sup>[2]</sup> The regimen was designed with a target trough concentration of 10 to 20 mg/L.</p>
<ul>
<li>PMA ≤29 weeks
			<ul>
<li>PNA ≤21 days: 15 mg/kg IV every 18 hours</li>
<li>PNA &gt;21 days: 15 mg/kg IV every 12 hours</li>
</ul>
</li>
<li>PMA 30 to &lt;37 weeks
			<ul>
<li>PNA ≤14 days: 15 mg/kg IV every 12 hours</li>
<li>PNA &gt;14 days: 15 mg/kg IV every 8 hours</li>
</ul>
</li>
<li>PMA 37 to &lt;45 weeks
			<ul>
<li>PNA ≤7 days: 15 mg/kg IV every 12 hours</li>
<li>PNA &gt;7 days: 15 mg/kg IV every 8 hours</li>
</ul>
</li>
</ul>
<p class="extra_spacing_top">◊ The approach to vancomycin dosing is generally determined at the institutional level. Refer to UpToDate content on invasive staphylococcal infections in children for details of trough-guided and AUC-guided vancomycin dosing.</p></div><div class="graphic_reference">References:
	<ol>
<li>Capparelli EV, Lane JR, Romanowski GL, et al. The influences of renal function and maturation on vancomycin elimination in newborns and infants. J Clin Pharmacol 2001; 41:927.</li>
<li>Radu L, Bengry T, Akierman A, et al. Evolution of empiric vancomycin dosing in a neonatal population. J Perinatol 2018; 38:1702.</li>
</ol>
<p class="extra_spacing_top">Data adapted from: American Academy of Pediatrics. Tables of antibacterial drug dosages. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32<sup>nd</sup> ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.876.</p></div><div id="graphicVersion">Graphic 51833 Version 25.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
